Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral
Clinical trial NCT04025567 · WITHDRAWN
Trial details
- NCT number
- NCT04025567
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-12
- Primary completion
- 2021-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.